Xylocor Therapeutics, Inc.
Biotechnology company · Malvern, Pennsylvania, United States
Xylocor Therapeutics, Inc. is a biotechnology company headquartered in Malvern, Pennsylvania, United States. Its earliest recorded incorporation is in 2013. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $300,000 in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $4 million sold in a notice filed in 2021.
Xylocor Therapeutics at a glance
What does Xylocor Therapeutics do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $300,000 in total (2023). NIH funding came from the National Heart, Lung, and Blood Institute.
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $4 million sold (2021).
Frequently asked questions about Xylocor Therapeutics
Where is Xylocor Therapeutics headquartered?
Xylocor Therapeutics, Inc. is headquartered in Malvern, Pennsylvania, United States.
What does Xylocor Therapeutics do?
Xylocor Therapeutics, Inc. is a biotechnology company.
When was Xylocor Therapeutics founded?
The earliest incorporation on record for Xylocor Therapeutics, Inc. is in 2013, according to public company registers.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.